Investigation of HIV in amniotic fluid from HIV-infected pregnant women at full term

Journal of Infectious Diseases

Volumn 192, Issue 3, 2005, Pages 488-491

  Mohlala, Boshishi K F ^a   Tucker, Timothy J ^a,b   Besser, Mitchell J ^a   Williamson, Carolyn ^a   Yeats, Jane ^a   Smit, Lynette ^a   Anthony, John ^a   Puren, Adrian ^c  

^a UNIVERSITY OF CAPE TOWN   (South Africa)

^b SOUTH AFRICAN MEDICAL RESEARCH COUNCIL   (South Africa)

^c NATIONAL INSTITUTE FOR COMMUNICABLE DISEASES   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN; NEVIRAPINE; VIRUS RNA; ZIDOVUDINE;

ADULT; AMNION FLUID ANALYSIS; ARTICLE; CESAREAN SECTION; CLINICAL ARTICLE; CYTOMEGALOVIRUS; DIAGNOSTIC VALUE; DNA EXTRACTION; FEMALE; FETUS; FETUS BLOOD; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MATERNAL BLOOD; POLYMERASE CHAIN REACTION; PREGNANCY; PRIORITY JOURNAL; T LYMPHOCYTE SUBPOPULATION; UMBILICAL CORD BLOOD; VERTICAL TRANSMISSION; VIRUS DETECTION; VIRUS LOAD; VIRUS TRANSMISSION;

ADOLESCENT; ADULT; AMNIOTIC FLUID; ANTI-HIV AGENTS; CYTOMEGALOVIRUS; DISEASE TRANSMISSION, VERTICAL; FEMALE; FETAL BLOOD; HIV INFECTIONS; HIV-1; HUMANS; INFANT, NEWBORN; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; PREGNANCY TRIMESTER, THIRD; VIRAL LOAD;

EID: 22544454428     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/431604     Document Type: Article

References (23)

1. Minkoff H. Human immunodeficiency virus infection in pregnancy. Obstet Gynecol 2003; 101:797-810.
2. Newell ML, Gray G, Bryson YJ. Prevention of mother-to-child transmission of HIV-1 infection. AIDS 1997; 11(Suppl A):S165-72.
3. Working Group on Mother-to-Child Transmission of HIV. Rates of mother-to-child transmission of HIV-1 in Africa, America, and Europe: results from 13 perinatal studies. J Acquir Immune Defic Syndr Hum Retrovirol 1995; 8:506-10.
4. Simonon A, Lepage P, Karita E, et al. An assessment of the timing of mother-to-child transmission of human immunodeficiency virus type 1 by means of polymerase chain reactions. J Acquir Immune Defic Syndr 1994; 7:952-7.
5. European Collaborative Study. Risk factors for mothcr-to-child transmission of HIV-1. Lancet 1992; 339:1007-12.
6. Landesman S, Kalish L, Burns D, et al. The relationship of obstetrical factors to the mother-to-child transmission of HIV-1. Obstetrical factors and the transmission of human immunodeficiency virus type 1 from mother to child. The Women and Infants Transmission Study. N Engl J Med 1996; 334:1617-23.
7. Mandelbrot L, Le Chenadec J, Berrebi A, et al. Perinatal HIV-1 transmission: interaction between zidovudine prophylaxis and mode of delivery in the French Perinatal Cohort. JAMA 1998; 280:55-60.
8. Kind C, Rudin C, Siegrisi CA, Wyler CA, et al. Prevention of vertical HIV transmission: additive protective effect of elective cesarean section and zidovudine prophylaxis. AIDS 1998; 12:205-10.
9. The International Perinatal HIV Group. The mode of delivery and the risk of vertical transmission of human imunodeficiency virus type 1-a meta-analysis of 15 prospective cohort studies. N Engl J Med 1999; 340:977-87.
10. The European Mode of Delivery Collaboration. Elective caesarcan section versus vaginal delivery in prevention of vertical HIV-1 transmission: a randomised clinical trial. Lancet 1999; 353:1035-9.
11. Wade NA, Birkhead GS, Warren BL, et al. Abbreviated regimens of zidovudine prophylaxis and perinatal transmission of human immunodeficiency virus. N Engl J Med 1998; 339:1409-14.
12. Dabis F, Msellati P, Meda N, et al. 6-month efficacy, tolerance and acceptability of a short regimen of oral zidovudine to reduce vertical transmission of HIV in breastfed children in Cote d'lvoire and Burkina Faso: a double blind placebo controlled multicentre trial. Lancet 1999; 353:786-92.
13. Wiktor SZ, Ekpini E, Karon JM, et al. Short course oral zidovudine for prevention of mother-to-child transmission of HIV-1 in Abidjan, Cote d'lvoire: a randomized trial. Lancet 1999; 353:781-5.
14. Guay LA, Musokc P, Fleming T, et al. Intrapartum and neonatal single-dose nevirapine compared with zidovudine for prevention of mother-to-child transmission of HIV-1 in Kampala, Uganda: HIVNET 012 randomised trial. Lancet 1999; 354:795-802.
15. Lin HH, Kao IH, Hsu HY, Mizokami M, Hirano K, Chen DS. Least microtransfusion from mother to fetus in elective cesarean delivery. Obstet Gynecol 1996; 87:244-8.
16. Mundy DC, Schinazi RF, Gerber AR, Nahmias AJ, Randall HW. Human immunodeficiency virus isolated from amniotic fluid. Lancet 1987; 2: 459-60.
17. Ishigaki S, Takeda M, Kura T, et al. Cytomegalovirus DNA in the sera of patients with Cytomegalovirus pneumonia. Br J Haematol 1991; 79: 198-204.
18. Cox SM, King MR, Casey ML, MacDonald PC. Interleukin-1β, -1α and -6 and prostaglandins in vaginal/cervical fluids of pregnant women before and during labor. J Clin Endocrinol Metab 1993; 77:805-15.
19. Schall TJ, Bacon KB. Chemokines, leukocyte trafficking, and inflammation. Curr Opin Immunol 1994; 6:865-73.
20. Liggins GC. Cervical ripening as an inflammatory reaction. In: Ellwood DA, Anderson ABM, eds. The cervix in pregnancy and labour: clinical and biochemical investigation. Edinburgh: Churchill Livingstone, 1981: 1-9.
21. Osmers R, Rath W, Adelmann-Grill BC, et al. Origin of cervical collagenase during parturition. Am J Obstet Gynecol 1992; 166:1455-60.
22. Junqueira LCU, Zugaib M, Montes GS, Toledo OM, Krisztan RM, Shigihara KM. Morphological and histochemical evidence for the occurrence of collagenolysis and for the role of neutrophilic polymorphonuclear leukocytes during cervical dilation. Am J Obstet Gynecol 1980; 138:273-81.
23. Chwalisz K, Benson M, Scholz P, Daum J, Beier HM, Hegele-Hartung C. Cervical ripening with the cytokines interleukin-8, interleukin-1β and tumour necrosis factor α in guinea-pigs. Hum Reprod 1994; 9: 2173-81.